Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys to Acquire SciTegic for $21.5M in Cash and Stock

NEW YORK, Sept. 14 (GenomeWeb News) - Accelrys plans to acquire SciTegic, a provider of workflow software for research, for about $21.5 million in cash and stock, the company said today.

 

San Diego-based SciTegic will become a wholly-owned subsidiary of Accelrys, which plans to incorporate SciTegic's Pipeline Pilot software into its portfolio.

 

Shareholders of SciTegic will receive $12.25 million of cash and approximately one million shares of Accelrys common stock in exchange for their SciTegic shares at closing, and about 300,000 additional Accelrys shares over the next two years. The acquisition is subject to approval by SciTegic shareholders and is expected to close this month.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.